A diabetic foot ulcer is an open sore or wound and it is said to be as a severe public health issue.
Two to ten percent of diabetics have foot ulcers and 25% of the diabetic population is at risk of DFU in their life time. The risk of developing a diabetic foot ulcer increases with in time. So as to deal with the problem of diabetic Foot Ulcer various treatment are getting introduced every new day. DFU treatments, usually include control of blood sugar, removal of dead tissue, wound dressings, and negative pressure therapy. Hyperbaric oxygen therapy may be beneficial but is costly and in some cases, surgery may also improve results.
However, certain metabolic disorders such as diabetes mellitus delays typical pace of wound healing process. So, apart from treatments there have been many drugs are introduced which are been helpful to ulcer patients till now. The market of DFU treatment has been classified into main four regions that are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
According the surveys which are been done till yet shows that North America is leading in the market because of diabetic patients and adequate healthcare facilities in the region are key factors responsible for the growth of the regional market. Europe held the second largest share in the market, followed by Asia Pacific.
Some of the prominent companies operating in the DFU treatment market are ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast A/S; Smith & Nephew Plc.; B. Braun Melsungen AG; Medline Industries, Inc.; Medtronic Plc.; Organogenesis, Inc. The players focus on alliances, strategic planning, new treatment planning, and research activities to achieve favorable growth.
Currently, Smith & Nephew, Coloplast, CovanTec, Acelity and 3M Healthcare are leading the market, supported by strong sales of their marketed therapeutic options for the treatment of diabetic foot ulcer. According to IQ4I survey it has been estimated that the global market of DFU treatment will be reach to $21.4 billion.